Question one
In a patient with a bradycardia and adverse features, who does not respond to atropine, transcutaneous pacing should be considered as an interim measure.
Select one of the options and then select Confirm.
Select one of the options and then select Confirm.
That is right. In a patient with a bradycardia and adverse features, if there is no response to atropine or if atropine is unlikely to be effective, transcutaneous pacing should be considered as an interim measure.
That is not right. In a patient with a bradycardia and adverse features, if there is no response to atropine or if atropine is unlikely to be effective, transcutaneous pacing should be considered as an interim measure.
No, that is not right.
References
See chapters 8, 10 and 11 of the ALS manual for further reading about about bradycardia.
Adult bradycardia algorithm
The adult bradycardia algorithm from chapter 11 of the ALS manual.
Settings
Font colour
default inverted high contrast high contrast inverted high contrast soft green on blackSample text
text looks like thisTEXT LOOKS LIKE THIS